A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Clinical trial NCT05836623 · UNKNOWN

Trial details

NCT number: NCT05836623
Sponsor: Crescendo Biologics Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced and/or Metastatic Solid Tumours

Start date: 2022-12-20
Primary completion: 2024-01-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.